Is Wang Laboratories Inc president Richard Miller simply fattening frogs for snakes as he pursues the gragantuan task of getting the company back on an even keel? In a shining example to debt-drowning companies like Unisys Corp, he has made eliminating Wang’s debt his top priority and the company now has an exemplary balance sheet with net cash, but the further 16% plunge in turnover for the most recent quarter makes Wang a classic acquisition target for a company with strong products and a weak marketing network, and it is hard to believe that Wang can thrive again as an independent company however strong its balance sheet.